2-benzyl-6-methyl-2,3,3a,8a-tetrahydro-1H-2-aza-cyclopenta[a]inden-8-one | 874990-46-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 2-benzyl-6-methyl-2,3,3a,8a-tetrahydro-1H-2-aza-cyclopenta[a]inden-8-one
• 英文别名: 2-Benzyl-6-methyl-1,3,3a,8b-tetrahydroindeno[1,2-c]pyrrol-4-one
• CAS: 874990-46-2
• 化学式: C₁₉H₁₉NO
• 分子量: 277.366
• InChiKey: IBJMUMZNQXANEP-UHFFFAOYSA-N

物化性质

• 沸点：
  418.2±44.0 °C(Predicted)
• 密度：
  1.180±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
  申请人：Bennani L. Youssef

  公开号：US20060025601A1

  公开（公告）日：2006-02-02

  The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are tricyclic indeno-pyrrole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).

  本发明一般涉及一系列化合物、含有这些化合物的药物组合物，以及这些化合物和组合物作为治疗剂的使用。更具体地，本发明的化合物是三环茚并吡咯化合物。这些化合物是血清素受体（5-HT）的配体，可用于治疗需要调节血清素受体（5-HT）活性的疾病、障碍和状况（例如焦虑、抑郁和肥胖）。
• TRICYCLIC INDENO-PYRROLE DERIVATIVES AS SEROTONIN RECEPTOR MODULATORS
  申请人：Bennani Youssef L.

  公开号：US20090239925A1

  公开（公告）日：2009-09-24

  The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are tricyclic indeno-pyrrole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).

  本发明通常涉及一系列化合物，包括含有这些化合物的药物组合物，以及将这些化合物和组合物用作治疗剂。更具体地说，本发明的化合物是三环吲哚-吡咯化合物。这些化合物是血清素受体（5-HT）配体，可用于治疗需要调节血清素受体（5-HT）活性的疾病、障碍和病状（例如焦虑、抑郁和肥胖症）。
• Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators
  申请人：Bennani Youssef L.

  公开号：US20110172283A1

  公开（公告）日：2011-07-14

  The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are tricyclic indeno-pyrrole compounds. These compounds are serotonin receptor (5-HT) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT) is desired (e.g. anxiety, depression and obesity).

  本发明通常涉及一系列化合物，含有这些化合物的制药组合物，以及将这些化合物和组合物用作治疗剂的用途。更具体地说，本发明的化合物是三环吲哚-吡咯化合物。这些化合物是血清素受体（5-HT）配体，可用于治疗需要调节血清素受体（5-HT）活性的疾病、疾病和病情（例如焦虑、抑郁和肥胖症）。
• US7935830B2
  申请人：——

  公开号：US7935830B2

  公开（公告）日：2011-05-03
• US8232311B2
  申请人：——

  公开号：US8232311B2

  公开（公告）日：2012-07-31